Encompass Health Analysis (March 2026) | Price Development & Price Target

Encompass Health

NYSE:EHC

$ 97,57

$-0,17 (-0,17%)

97,57 $

$-0,17 (-0,17%)

End-of-day quote: 03/27/2026

Encompass Health Stock Value

The analyst rating for NYSE:EHC is currently Buy.

Buy

Encompass Health Company Info

EPS Growth 5Y

2,53%

Market Cap

$9,70 B

Long-Term Debt

$2,45 B

Short Interest

2,60%

Annual earnings

N/A

Dividend

$0,76

Dividend Yield

0,78%

Founded

1984

Industry

Health Care

Country

United States

ISIN Number

US29261A1007

Website

http://www.encompasshealth.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$140,00

43.49%

Last Update: 03/28/2026

Analysts: 11

Highest Price Target $160,00

Average Price Target $140,00

Lowest Price Target $130,00

In the last five quarters, Encompass Health’s Price Target has risen from $82,91 to $117,27 - a 41,44% increase. Twelve analysts predict that Encompass Health’s share price will increase in the coming year, reaching $140,00. This would represent an increase of 43,49%.

Top growth stocks in the health care sector (5Y.)

What does Encompass Health do?

Encompass Health Corporation provides post-acute healthcare services. The company owns and operates inpatient rehabilitation hospitals. The company provides specialized rehabilitative treatment on an inpatient basis. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company’s inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive, patient care services. As participan...

The company’s inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive, patient care services. As participants in the Medicare program, the company’s hospitals must be licensed and certified and otherwise comply with various requirements. Substantially all (91%) of the patients the company serves are admitted from acute-care hospitals following physician referrals for specific acute inpatient rehabilitative care. Most of those patients have experienced significant physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and a variety of debilitating neurological conditions, that are generally nondiscretionary in nature and require rehabilitative healthcare services in a facility-based setting.

The company focuses on specialized rehabilitative care has meant that in many cases its hospitals have been ideal settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity, and malnutrition. The company’s hospitals provide a comprehensive interdisciplinary clinical approach to treatment that leverages innovative technologies and advanced therapies and leads to superior outcomes.

Strategy and Strategic Priorities

The company’s overall strategy is to expand its network of inpatient rehabilitation hospitals, add capacity to existing hospitals, further strengthen its relationships with healthcare systems, provider networks, and payors in order to connect patient care across the healthcare continuum, and to deliver superior patient outcomes in a cost-effective manner. The company will continue to have organic growth opportunities within its same store hospitals based on its track record of growth, secular shifts in aging demographic populations, its ability to capture market share, and the maturation of newly opened locations. The company has pursued and will continue to pursue initiatives to lower its rate of transfers to acute-care hospitals, improve its rate of discharges to community, and improve the patient experience.

The company will continue to demonstrate its value proposition to Medicare Advantage payors by providing superior patient outcomes, including higher discharge to community rates and lower lengths of stay, compared to alternative sites of care. The company’s outcomes and quality of care data have helped drive significant improvement in the payments it receives from Medicare Advantage payors.

The company will continue to develop and implement post-acute solutions that allow it to apply its clinical expertise, large post-acute datasets, electronic medical record technologies, and strategic partnerships to drive improved patient outcomes. The company will seek to expand efforts and initiatives to recruit and retain a qualified clinical workforce. The company will continue to install in its hospitals a hemodialysis system with which it is able to provide inpatient dialysis to its patients without relying on third-parties. Historically, the company’s patients have received dialysis from third-party vendors, either onsite or offsite as available, often resulting in interruptions to their therapy schedules. With this new onsite hemodialysis system, the company can provide its patients dialysis without interrupting therapy or requiring patient travel.

Regulations

The company undertakes significant effort and expense to provide the medical, nursing, therapy, and ancillary services required to comply with local, state, and federal regulations, as well as, for most hospitals, accreditation standards of The Joint Commission and, for some hospitals, the Commission on Accreditation of Rehabilitation Facilities. Accredited hospitals are subject to periodic resurvey to ensure the standards are being met. All of the company’s inpatient hospitals participate in the Medicare program.

History

The company was founded in 1984. It was incorporated in Delaware in 1984. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in 2018.

Encompass Health Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Industry Revenues:** - Rehabilitation Services: approx. 75% - Home Health and Hospice Services: approx. 25% **TOP 3 Markets:** 1. USA Southeast: approx. 40% 2. USA Southwest: approx. 30% 3. USA Northeast: approx. 15% Encompass Health Corporation generates the majority of its revenues from rehabi...

At which locations are the company’s products manufactured?

**Locations of Rehabilitation Clinics:** Over 150 locations in the USA (2023) Encompass Health Corporation is a leading company in the field of rehabilitation services and operates a network of rehabilitation clinics in the United States. The company does not produce physical products in the tradit...

What strategy does Encompass Health pursue for future growth?

**Revenue Growth:** Estimated 6-8% annually (2025) **Strategic Orientation:** Expansion of the rehabilitation business and expansion into new markets Encompass Health Corporation pursues a growth strategy focusing on strengthening and expanding its rehabilitation business. The company plans to exp...

Which raw materials are imported and from which countries?

**Main materials:** Medical devices, rehabilitation equipment, IT systems **Countries of origin:** USA, Germany, China Encompass Health Corporation is a leading company in the field of rehabilitation and healthcare services. The company mainly imports medical devices and rehabilitation equipment t...

How strong is the company’s competitive advantage?

**Market share:** 17% in the rehabilitation sector (2025, estimate) **EBITDA margin:** 20.5% (2024) **Return on invested capital (ROIC):** 12.3% (2024) Encompass Health Corporation has a significant competitive advantage in the rehabilitation sector, which is manifested by a high market share o...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approx. 91% (2025, estimated) **Insider Buys/Sells:** No significant transactions in the last quarter (2025, estimated) The institutional investor share in Encompass Health Corporation is traditionally high, indicating the trust of large investment funds and insti...

What percentage market share does Encompass Health have?

**Market share of Encompass Health Corporation:** Estimated 10% (2025) **Top competitors and their market share:** 1. **Select Medical Holdings Corporation:** 12% 2. **Kindred Healthcare:** 9% 3. **Amedisys Inc.:** 8% 4. **LHC Group:** 7% 5. **Brookdale Senior Living:** 6% **Moat of Encompass Heal...

Is Encompass Health stock currently a good investment?

**Revenue Growth:** 8% (2024) **Profit Growth:** 10% (2024) **Market Share in the Rehabilitation Sector:** 20% (2024) Encompass Health Corporation achieved solid revenue growth of 8% in 2024, attributed to strong demand for rehabilitation services and effective expansion into new markets. The 10% p...

Does Encompass Health pay a dividend – and how reliable is the payout?

**Dividend Yield:** 1.5% (estimated for 2025) **Dividend History:** Continuous payout for several years Encompass Health Corporation has regularly distributed dividends in the past, demonstrating a certain reliability in its dividend policy. The estimated dividend yield of 1.5% for the year 2025...

New support ticket

Explore

Encompass Health Stock Value

Encompass Health Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Encompass Health do?

Encompass Health Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Encompass Health Stock Value

Encompass Health Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Encompass Health do?

Encompass Health Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.